Related Experiment Videos

[Cirrhogenic hepatitis due to perhexiline maleate: general review based upon one new case with ultrastructural study

Annales De Medecine Interne
|October 1, 1978
PubMed

Insights

Perhexiline maleate, used for angina, can cause liver cirrhosis. This case highlights the drug

Area of Science:

  • Hepatology
  • Toxicology
  • Pharmacology

Background:

  • Perhexiline maleate is a medication prescribed for severe angina pectoris.
  • Drug-induced liver injury is a significant concern in clinical practice.
  • Cirrhosis is a severe form of liver damage with various etiologies.

Observation:

  • A case of cirrhogenic hepatitis developed after 8 months of perhexiline maleate treatment.
  • The patient presented with liver cirrhosis, which was the initial manifestation of the condition.
  • Cirrhosis appeared to stabilize after discontinuation of the drug.

Findings:

  • The liver injury exhibited a cirrhogenic evolution, consistent with previously reported cases.
  • Mechanisms may involve cumulative drug effects or an immuno-allergic response.
  • Distinctive features include lysosomal overload with brown pigment and lipolysosomes, observable microscopically and electron microscopically.

Implications:

  • Perhexiline maleate prescription should be restricted to refractory angina cases.
  • Regular clinical and biological monitoring is crucial for patients on this medication.
  • Understanding the toxicological profile of perhexiline maleate is essential for patient safety.

Related Concept Videos